Journals / Turkish Journal of Medical Sciences / 2017 / Cilt: 47 - Sayı: 6

Parathyroid hormone in washout fluid seems to be superior to cytology for localization of the lesion in MIBI-negative patients with primary hyperparathyroidism

Pages
1703–1707
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Our results showed that when evaluating ambiguous lesions on neck ultrasound, measuring the PTH level in washout fluid of FNAB is a reliable and effective method for diagnosis of parathyroid lesions and is superior to FNAB for localization.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Primary hyperparathyroidism (PHPT) is characterized by increased calcium (Ca) and parathyroid hormone (PTH) levels.
📊
Key Findings & Data:Materials and methods: We retrospectively evaluated the medical records of 98 patients diagnosed with PHPT.
💡
Conclusion & Impact:Conclusion: Our results showed that when evaluating ambiguous lesions on neck ultrasound, measuring the PTH level in washout fluid of FNAB is a reliable and effective method for diagnosis of parathyroid lesions and is superior to FNAB for localization.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: Primary hyperparathyroidism (PHPT) is characterized by increased calcium (Ca) and parathyroid hormone (PTH) levels. Surgical removal of the culprit hyperfunctioning parathyroid gland is the preferred treatment. In this study, we aimed to determine whether PTH-washout or cytological examination of suspicious lesions was superior in MIBI-negative patients diagnosed with PHPT. Materials and methods: We retrospectively evaluated the medical records of 98 patients diagnosed with PHPT. Seventy-six patients who had positive parathyroid scintigraphy and who did not undergo parathyroidectomy in our center due to various reasons were excluded. We evaluated the remaining 22 patients with negative scintigraphy. Medical records including PTH levels in serum and washout fluid of fine-needle aspiration biopsy (FNAB), biochemical data, cytological results of FNAB, and histologic reports were reviewed. Results: The patients had a mean age of 50 ± 9 (31 72) years, serum Ca of 10.9 ± 0.5 (10.3 12.7) mg/dL, serum PTH of 285 ± 156 (107.2 679) pg/mL, and PTH of washout fluid of 19,523 ± 38,632 (1410 166,000) pg/mL. Cytological evaluation revealed insufficient material in 9 patients and cells of indeterminate origin in 4 patients. Conclusion: Our results showed that when evaluating ambiguous lesions on neck ultrasound, measuring the PTH level in washout fluid of FNAB is a reliable and effective method for diagnosis of parathyroid lesions and is superior to FNAB for localization.

🔖

Cite This Article

CANSU, G. B., TAŞKIRAN, B., CENGİZ, B. P., DİZEN, H. (2022). Parathyroid hormone in washout fluid seems to be superior to cytology for localization of the lesion in MIBI-negative patients with primary hyperparathyroidism. Turkish Journal of Medical Sciences, Cilt: 47 - Sayı: 6, 1703–1707. https://ajindex.com/articles/610573

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Rodgers SE, Lew JI, Solorzano CC. Primary hyperparathyroidism. Curr Opin Oncol 2008; 20: 52-58
  2. Wang CA. Surgical management of primary hyperparathyroidism. Curr Prob Surg 1985; 22: 1-50
  3. Boi F, Lombardo C, Cocco MC, Piga M, Serra A, Lai ML, Calò PG, Nicolosi A, Mariotti S. Thyroid diseases cause mismatch between MIBI scan and neck ultrasound in the diagnosis of hyperfunctioning parathyroids: usefulness of FNA-PTH assay. Eur J Endocrinol 2013; 168: 49-58
  4. Masatsugu T, Yamashita H, Noguchi S, Nishii R, Watanabe S, Uchino S, Kuroki S, Tanaka M. Significant clinical differences in primary hyperparathyroidism between patients with and those without concomitant thyroid disease. Surg Today 2005; 35: 351-356
  5. Doppman JL, Krudy AG, Marx SJ, Saxe A, Schneider P, Norton JA, Spiegel AM, Downs RW, Schaaf M, Brennan ME et al. Aspiration of enlarged parathyroid glands for parathyroid hormone assay. Radiology 1983; 148: 31-35
  6. Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, Potts JT Jr. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocr Metab 2014; 99: 3561-3569
  7. Koren I, Shpitzer T, Morgenshtern S, Shvero J. Lateral minimal parathyroidectomy: safety and cosmetic benefits. Am J Otolaryng 2005; 26: 83-86
  8. Miccoli P. Minimally invasive surgery for thyroid and parathyroid diseases. Surg Endosc 2002; 16: 3-6
  9. Felger EA, Kandil E. Primary hyperparathyroidism. Otolaryng Clin N Am 2010; 43: 417-432
  10. Johnson NA, Tublin ME, Ogilvie JB. Parathyroid imaging: technique and role in the preoperative evaluation of primary hyperparathyroidism. Am J Roentgenol 2007; 188: 1706-1715
  11. Meilstrup JW. Ultrasound examination of the parathyroid glands. Otolaryng Clin N Am 2004; 37: 763-778
  12. Solbiati L, Montali G, Croce F, Bellotti E, Giangrande A, Ravetto C. Parathyroid tumors detected by fine-needle aspiration biopsy under ultrasonic guidance. Radiology 198; 148: 793-797
  13. O’Doherty MJ, Kettle AG, Wells P, Collins RE, Coakley AJ. Parathyroid imaging with technetium-99m-sestamibi: preoperative localization and tissue uptake studies. J Nucl Med 199; 33: 313-318
  14. Mihai R, Gleeson F, Buley ID, Roskell DE, Sadler GP. Negative imaging studies for primary hyperparathyroidism are unavoidable: correlation of sestamibi and high-resolution ultrasound scanning with histological analysis in 150 patients. World J Surg 2006; 30: 697-704. 15.